Literature DB >> 6895380

The antinociceptive effects of intrathecally administered levonantradol and desacetyllevonantradol in the rat.

T L Yaksh.   

Abstract

Levonantradol and its desacetylated metabolite (desacetyllevonantradol) produced a dose-dependent increase in the hot plate and tail flick response latencies following intrathecal administration in a dose range from 4 to 40 micrograms. No difference in potency between the two drugs was observed, as defined by the ED50 values obtained in either test. The duration of the effect of either drug was also dose dependent ranging from 30 to 120 minutes. No effect on placing, stepping or righting reflexes or the ability of the rats to negotiate a 60 degrees inclined plane was observed at these doses. At the highest doses, however, an exaggerated myoclonic response to abrupt muscle stretch was observed. None of those effects was antagonized by naloxone (2 mg/kg) administered intraperitoneally before or after levonantradol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895380     DOI: 10.1002/j.1552-4604.1981.tb02612.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  14 in total

1.  Centrally mediated antinociceptive effects of cannabinoid receptor ligands in rat models of nociception.

Authors:  Aldric Hama; Jacqueline Sagen
Journal:  Pharmacol Biochem Behav       Date:  2011-09-17       Impact factor: 3.533

Review 2.  The endocannabinoid system and pain.

Authors:  Josée Guindon; Andrea G Hohmann
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

3.  Effects of fixed-interval duration on the development of tolerance to decreased responding by l-nantradol.

Authors:  J B Smith
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Effects of fixed-ratio length on the development of tolerance to decreased responding by l-nantradol.

Authors:  J B Smith
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.

Authors:  Sudeshna Ghosh; Laura E Wise; Yugang Chen; Ramesh Gujjar; Anu Mahadevan; Benjamin F Cravatt; Aron H Lichtman
Journal:  Life Sci       Date:  2012-06-28       Impact factor: 5.037

6.  Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.

Authors:  Steven G Kinsey; Pattipati S Naidu; Benjamin F Cravatt; David T Dudley; Aron H Lichtman
Journal:  Pharmacol Biochem Behav       Date:  2011-06-29       Impact factor: 3.533

Review 7.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

8.  Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia.

Authors:  J D Richardson; L Aanonsen; K M Hargreaves
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

9.  Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.

Authors:  H M Meinck; P W Schönle; B Conrad
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

10.  Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects.

Authors:  W J Martin; A G Hohmann; J M Walker
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.